Chemoresistance factors in non-small cell lung cancer
Lung cancer takes the leading position in cancer morbidity and mortality structure in the world and Ukraine. Advanced stages are diagnosed in more than 70% of lung cancer patients. Chemotherapy remains the main method of treatment for advanced lung cancer. Currently, the standard of chemotherapy in...
Saved in:
| Main Authors: | А. I. Shevchenko, А. P. Коlesnik, А. V. Каdzhoian, V. А. Кuzmenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2016-04-01
|
| Series: | Patologìâ |
| Subjects: | |
| Online Access: | http://pat.zsmu.edu.ua/article/view/71945/68172 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deferasirox’s Anti-Chemoresistance and Anti-Metastatic Effect on Non-Small Cell Lung Carcinoma
by: Yamixa Delgado, et al.
Published: (2024-10-01) -
Modern treatment approaches for patients with IV stage of non-small cell lung cancer
by: А. V. Kadzhoian
Published: (2013-06-01) -
CHEMOTHERAPY IN COMBINED MODALITY TREATMENT FOR LOCALLY ADVAMCED NON-SMALL CELL LUNG CANCER
by: Е. L. Yumov, et al.
Published: (2016-02-01) -
HYPERTHERMIA IN TREATMENT OF NON-SMALL CELL LUNG CANCER
by: А. Yu. Dobrodeev, et al.
Published: (2016-02-01) -
The interplay between COX-2, chemotherapeutic drugs, and chemoresistance in colon cancer
by: Sally M. Shalaby, et al.
Published: (2025-05-01)